1Bekkenk MW,Geelen FA,van Voorst-Vader PC,et al.Primary and secondary cutaneous CD30+ lymphoproliferative disorders:a report from the Dutch Cutaneous Lymphoma Group on the longterm follow-up data of 219 patients and guidelines for diagnosis and treatment[J].Blood,2000,95(12):3653-3661.
2Croager E,Gout AM,Abraham L.Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene[J].Am J Pathol,2000,156(5):1723-1731.
3Durkop H,Oberbarnscheidt M,Latza U,et al.The restricted expression pattern of the Hodgkin's lymphoma-associated cytokine receptor CD30 is regulated by a minimal promoter[J].J Pathol,2000,192(2):182-193.
4Horie R,Watanabe T,Morishita Y,et al.Ligand-independent signaling by overexpressod CD30 derives NF-κB activation in Hodgkin-Beed Sternberg cell[J].Oncogene,2002,2 (16)1:2493-2503.
5Bargou RC,Emmerich F,Krappman D,et al.Constitutive expression of NF-κB is a characteristic feature of mycosis fungoides:implications for apoptosis resistance and pathogenesis[J].Hum Pathol,2000,31 (12):1482-1490.
8Mori M,Manuelli C,Pimpinelli N,et al.CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas:a clue to the pathopbysiology of clinical regression[J].Blood,1999,94 (9):3077-3083.
9Huhn M,Sasso S,Tur MK,et al.Human angingenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30 positive lymphoma[J].Cancer Res,2001,61 (24):8737-8742.
10Wang KC,Cheng AL,Chusng SE,et al.Retinoic acid-induced apoptotic pathway in T-cell lymphoma:identification of four groups of genes with differential biological functious[J].Exp Hematol,2000,28(28):1441-1450.
8Willemze R,Jaffe ES,Burg G,et al.WHO-EORTC classification for cutaneous lymphomas.Blood,2005,105(10):3768-3785.
9Atkins KA,Dahlem MM,Kohler S.A case of lymphomatoid papulosis with prominent myxoid change resembling a mesenchymal neoplasm.Am J Dermatopathol,2003,25(1):62-65.
10El Shabrawi-Caelen L,Kerl H,Cerroni L.Lymphomatoid papulosis:reappraisal of clinicopathologic presentation and classification into subtypes A,B,and C.Arch Dermatol,2004,140(4):441-447.
